Point-of-care testing by healthcare workers for detection of meticillin-resistant Staphylococcus aureus, Clostridioides difficile, and norovirus - PubMed (original) (raw)
Comparative Study
. 2019 Dec;103(4):447-453.
doi: 10.1016/j.jhin.2019.08.002. Epub 2019 Aug 9.
Affiliations
- PMID: 31404566
- DOI: 10.1016/j.jhin.2019.08.002
Comparative Study
Point-of-care testing by healthcare workers for detection of meticillin-resistant Staphylococcus aureus, Clostridioides difficile, and norovirus
S Dewar et al. J Hosp Infect. 2019 Dec.
Abstract
Background: The feasibility of introducing three separate Cepheid GeneXpert® assays was assessed: Xpert SA Nasal Complete, Xpert C. difficile, and Xpert Norovirus for point-of-care testing (POCT) on a ward in a district general hospital.
Aim: To establish a seven-day/24 h POCT service for meticillin-resistant Staphylococcus aureus (MRSA), Clostridioides difficile, and norovirus operated solely by healthcare workers (HCWs).
Methods: The Cepheid GeneXpert assays performance characteristics were assessed by comparing the assays to traditional central laboratory methods in terms of clinical turnaround times, hands-on time, number of process steps, time to result and diagnostic accuracy. HCW feedback was collected to consider the potential added value of applying this technology to improve patient flow and clinical care.
Findings: In total 1170 tests were carried out over the 16-month study period. The assays significantly reduced hands-on time, process steps, and time to result for identification of all three micro-organisms. Overall agreement with central laboratory testing was >98% for all three assays. Staff members fed back that POCT had a positive impact in terms of clinical utility.
Conclusion: Xpert SA Nasal Complete for MRSA detection, Xpert C. difficile, and Xpert Norovirus can be used as POCT solely by HCWs in a ward setting. Each assay was used throughout a seven-day/24 h period with potential positive impact on bed management and patient care.
Keywords: Cepheid; Clostridioides difficile; MRSA; Norovirus; POCT; Point-of-care.
Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.
Similar articles
- Use of Xpert® MRSA PCR point-of-care testing beyond the laboratory.
Parcell BJ, Phillips G. Parcell BJ, et al. J Hosp Infect. 2014 Jun;87(2):119-21. doi: 10.1016/j.jhin.2014.04.002. Epub 2014 Apr 18. J Hosp Infect. 2014. PMID: 24836293 - A service evaluation of simultaneous near-patient testing for influenza, respiratory syncytial virus, Clostridium difficile and norovirus in a UK district general hospital.
Haigh J, Cutino-Moguel MT, Wilks M, Welch CA, Melzer M. Haigh J, et al. J Hosp Infect. 2019 Dec;103(4):441-446. doi: 10.1016/j.jhin.2019.08.022. Epub 2019 Sep 5. J Hosp Infect. 2019. PMID: 31494128 - Performance of the Cepheid Xpert® SA Nasal Complete PCR assay compared to culture for detection of methicillin-sensitive and methicillin-resistant Staphylococcus aureus colonization.
Patel PA, Schora DM, Peterson KE, Grayes A, Boehm S, Peterson LR. Patel PA, et al. Diagn Microbiol Infect Dis. 2014 Sep;80(1):32-4. doi: 10.1016/j.diagmicrobio.2014.05.019. Epub 2014 May 21. Diagn Microbiol Infect Dis. 2014. PMID: 24952987 - Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species.
Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Weber DJ, et al. Am J Infect Control. 2010 Jun;38(5 Suppl 1):S25-33. doi: 10.1016/j.ajic.2010.04.196. Am J Infect Control. 2010. PMID: 20569853 Review. - Should healthcare workers be screened routinely for meticillin-resistant Staphylococcus aureus? A review of the evidence.
Hawkins G, Stewart S, Blatchford O, Reilly J. Hawkins G, et al. J Hosp Infect. 2011 Apr;77(4):285-9. doi: 10.1016/j.jhin.2010.09.038. Epub 2011 Feb 2. J Hosp Infect. 2011. PMID: 21292349 Review.
Cited by
- Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis.
Ojha SC, Chen K, Sun C, Ahmed S, Sheng YJ, Deng CL. Ojha SC, et al. Infect Dis Ther. 2022 Jun;11(3):1205-1227. doi: 10.1007/s40121-022-00632-w. Epub 2022 Apr 22. Infect Dis Ther. 2022. PMID: 35451743 Free PMC article. - Cost Consequences for the NHS of Using a Two-Step Testing Method for the Detection of Clostridium difficile with a Point of Care, Polymerase Chain Reaction Test as the First Step.
Jones WS, Rice S, Power HM, Maniatopoulos G, Suklan J, Beyer F, Wilcox MH, Permain M, Simpson AJ, Price DA, Allen AJ. Jones WS, et al. Diagnostics (Basel). 2020 Oct 14;10(10):819. doi: 10.3390/diagnostics10100819. Diagnostics (Basel). 2020. PMID: 33066456 Free PMC article. - Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions.
Banerjee R, Patel R. Banerjee R, et al. JAC Antimicrob Resist. 2023 Feb 17;5(1):dlad018. doi: 10.1093/jacamr/dlad018. eCollection 2023 Feb. JAC Antimicrob Resist. 2023. PMID: 36816746 Free PMC article. Review. - Recent Developments in Phenotypic and Molecular Diagnostic Methods for Antimicrobial Resistance Detection in Staphylococcus aureus: A Narrative Review.
Sanchini A. Sanchini A. Diagnostics (Basel). 2022 Jan 15;12(1):208. doi: 10.3390/diagnostics12010208. Diagnostics (Basel). 2022. PMID: 35054375 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical